$12.870
-0.236 (-1.83%)At close
NTLA News
NTLA Events
Intellia Q2 Revenue $7.66M, Below Consensus
Reports Q2 revenue $7.66M, consensus $12.98M. "The second quarter was a momentous period for Intellia highlighted by the positive Phase 3 HAELO clinical trial results we reported for lonvo-z in hereditary angioedema," said John Leonard, Intellia President and Chief Executive Officer. "These data serve as strong validation for in vivo gene editing and lonvo-z's potential to transform the treatment paradigm for patients who are burdened by this disease."
Intellia Therapeutics Stock Rises 12.9% to $16.43
Intellia Therapeutics is up 12.9%, or $1.88 to $16.43.
Intellia Therapeutics Stock Rises 10.7% to $16.11
Intellia Therapeutics is up 10.7%, or $1.56 to $16.11.
Major U.S. Indices Surge on U.S.-Iran Peace Agreement
The major averages finished sharply higher following a preliminary U.S.-Iran peace agreement that could reopen the Strait of Hormuz and significantly ease pressure on global energy markets. Brent crude oil prices have dropped to roughly three-month lows after the announced agreement, easing concerns about supply disruptions and helping reduce inflation fears that had weighed on stocks throughout the spring.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Fox Corp.Rokufor $160 per shareSalesforcecustomer agent company Fin for $3.6BNuveiPayoneer Globalfor $7.40 per share in cash, or $2.75BTripAdvisorto American Expressfor $700M in cashThe U.K. government isfor children under the age of 162. WALL STREET CALLS:TruistDatadogto Buy, sees opportunity for continued upsideOld Dominionto Sell at CitiKeyBancFireFly Aerospaceand Rocket Labto Overweight after their SpaceX related selloffsAccentureto Equal Weight at Morgan StanleyFerrarito Overweight at Morgan Stanley3. AROUND THE WEB:Centeneis offering voluntary buyouts to most employees, Bloomberg reportsTeslarecently presented self-published safety statistics to regulators in Sweden and Netherlands, but independent traffic-safety researchers argue the statistics are misleading marketing, Reuters saysMatt Holt's investment firm Thoreau Group, which is backed by Apollo Global, is in advanced discussions to acquire Ensemble Health Partners in a deal that would value the company at roughly $12B, Bloomberg saysSBA Communications'potential take-private process involving KKRand Brookfieldhas stalled and is now considered effectively dead, as negotiations have come to a standstill in recent weeks, sources tell GreenstreetAccording to an Indian pollution regulator, wastewater from a Tata components factory for Apple'siPhone has allegedly contaminated groundwater, impacting nearby farms, Reuters says4. MOVERS:Oustergained afterwith Benchmark ElectronicsIntellia Therapeuticsincreased after presenting resultsStriveclosed higher afterand reporting holdings of 19,105 as of June 12Pattern Groupfinished lower afterAlcoafell after announcing the ratification of a5. EARNINGS/GUIDANCE:PowerFleet, with EPS and revenue beating consensusCoda Octopus, with EPS higher year-over-yearFiservbacked itsenGene, with EPS beating consensusJerash Holdingsand provided guidance for Q1INDEXES:The Dow rose 468.77, or 0.92%, to 51,671.03, the Nasdaq gained 795.10, or 3.07%, to 26,683.94, and the S&P 500 advanced 122.83, or 1.65%, to 7,554.29.
Major Averages Surge on U.S.-Iran Peace Agreement
The major averages were sharply higher near noon as investors return from the weekend focused on a preliminary U.S.-Iran peace agreement that could reopen the Strait of Hormuz and significantly ease pressure on global energy markets. Brent crude oil prices have dropped to roughly three-month lows after the announced agreement, easing concerns about supply disruptions and helping reduce inflation fears that had weighed on stocks throughout the spring.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Fox Corp.Rokufor $160 per shareSalesforcecustomer agent company Fin for $3.6BNuveiPayoneer Globalfor $7.40 per share in cash, or $2.75BTripAdvisorwillto American Expressfor $700M in cashThe U.K. government isfor children under the age of 162. WALL STREET CALLS:TruistDatadogto Buy, sees opportunity for continued upsideOld Dominionto Sell at CitiKeyBancFireFly Aerospaceand Rocket Labto Overweight after their SpaceX related selloffsAccentureto Equal Weight at Morgan StanleyFerrarito Overweight at Morgan Stanley3. AROUND THE WEB:CommerzbankCEO Bettina Orlopp said the bank was surprised by allegations from UniCreditthat it had misled the public, highlighting rising tensions between the two banks, Reuters saysTeslarecently presented self-published safety statistics to regulators in Sweden and Netherlands, but independent traffic-safety researchers argue the statistics are misleading marketing, Reuters saysMatt Holt's investment firm Thoreau Group, which is backed by Apollo Global, is in advanced discussions to acquire Ensemble Health Partners in a deal that would value the company at roughly $12B, Bloomberg saysSBA Communications'potential take-private process involving KKRand Brookfieldhas stalled and is now considered effectively dead, as negotiations have come to a standstill in recent weeks, sources tell GreenstreetAccording to an Indian pollution regulator, wastewater from a Tata components factory for Apple'siPhone has allegedly contaminated groundwater, impacting nearby farms, Reuters says4. MOVERS:Oustergains afterwith Benchmark ElectronicsIntellia Therapeuticsincreases afterfrom its Phase 3 HAELO trialStrivehigher afterand reporting holdings of 19,105 as of June 12Pattern Grouplower after filing toAlcoafalls after announcing the ratification of awith USW5. EARNINGS/GUIDANCE:PowerFleet, with EPS and revenue beating consensusCoda Octopus, with EPS higher year-over-yearFiservfor FY26enGene, with EPS beating consensusJerash Holdingsand provided guidance for Q1INDEXES:Near midday, the Dow was up 1.37%, or 703.88, to 51,906.14, the Nasdaq was up 2.99%, or 773.00, to 26,661.85, and the S&P 500 was up 1.91%, or 141.58, to 7,573.04.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.






